Portfolio

Top Stocks

Quarterly Top 10 Holdings

as of 29-Dec-2017

GW Pharmaceuticals Plc 10.79%
Scotts Miracle-Gro Comapny (The) 10.59%
Abbott Laboratories 6.37%
Microsoft Corporation 6.05%
Cannabis Science Inc. 5.02%
Solis Tek Inc. 4.28%
AbbVie Inc. 4.10%
Cara Therapeutics Inc. 3.86%
Innovative Industrial Properties, Inc. 3.86%
Merck & Company Inc. 3.71%

Top Portfolio Holdings

as of 29-Dec-2017

1. GW Pharmaceuticals PLC (GWPH)
GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant.
2. Scotts Miracle-Gro Company (SMG)
Hydroponics is the process of growing plants in liquids without the use of soil and is a popular method for cultivating marijuana.
3. Abbott Laboratories (ABT)
Manufactures Dexanabinol: A synthetic cannabinoid that protects the brain from damage (cardiac surgery), regain memory and other high-level functions following traumatic brain injury. Possible future use as an anti-cancer drug.
4. Microsoft Corp (MSFT)
Microsoft is developing a new product in Microsoft's cloud computing business that is meant to help states that have legalized the medical or recreational use of marijuana. The software is meant to keep tabs on sales and commerce, ensuring that they remain in the daylight of legality.
5. Cannabis Stavia Inc (CBDS)
Cannabis Sativa Inc and its subsidiary are engaged in research, development and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems.
6. Solis Tek Inc (SLTK)
Solis Tek introduces contorller for enhanced cannabis cultivation
7. AbbVie Inc. (ABBV)
AbbVie offers drug capsules - Marinol which is part of a class of medications called cannabinoids. Marinol treats nausea and vomiting caused by chemotherapy and restores hunger in AIDS patients.
8. Cara Therapeutics Inc. (CARA)
Cara is developing lead molecules that selectively modulate peripheral CB receptors without targeting CNS cannabinoid receptors.
9. Innovative Industrial Properties, Inc. (IIPR)
The Company is engaged in the acquisition, ownership and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities
10. Merck & Company Inc. (MRK)
Looking to acquire marijuana based drug companies.